STRATA Skin Sciences, Inc.
SSKN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $110,789 | $192,062 | $274,227 | $498,837 |
| - Cash | $7,261 | $6,784 | $5,434 | $12,586 |
| + Debt | $16,439 | $15,633 | $8,441 | $8,029 |
| Enterprise Value | $119,967 | $200,911 | $277,234 | $494,280 |
| Revenue | $33,562 | $33,358 | $36,161 | $29,977 |
| % Growth | 0.6% | -7.8% | 20.6% | – |
| Gross Profit | $19,081 | $18,461 | $21,768 | $19,850 |
| % Margin | 56.9% | 55.3% | 60.2% | 66.2% |
| EBITDA | -$2,842 | -$3,380 | $1,128 | $1,728 |
| % Margin | -8.5% | -10.1% | 3.1% | 5.8% |
| Net Income | -$10,086 | -$10,830 | -$5,549 | -$2,706 |
| % Margin | -30.1% | -32.5% | -15.3% | -9% |
| EPS Diluted | -0.26 | -0.31 | -0.16 | -0.08 |
| % Growth | 16.1% | -93.8% | -101.3% | – |
| Operating Cash Flow | $188 | -$519 | -$1,108 | $1,508 |
| Capital Expenditures | -$1,636 | -$5,019 | -$3,552 | -$3,653 |
| Free Cash Flow | -$1,448 | -$5,538 | -$4,660 | -$2,145 |